Search for Clinical Trial Results

Sponsored By

IgA Nephropathy - 14 Studies Found

Status Study
Completed Study Name: The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease
Condition: Primary IgA Nephropathy
Date: 2012-07-25
Interventions:
  • Drug: NEFECON All patients wil
Completed Study Name: Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy
Condition: IgA Nephropathy
Date: 2007-10-29
Interventions:
  • Drug: supportive therapy with: ACE-inhibitor / ARB / Statin

Completed Study Name: Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers
Condition: IgA Nephropathy
Date: 2010-11-08
Interventions: Drug: Calcitriol Calcitriol(1,25-dihydroxycholecalciferol, vitamin D3 analog)0.25 μg per day
Recruiting Study Name: Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy
Condition: IgA Nephropathy
Date: 2016-11-24
Interventions:
  • Drug: Mycophenolate Mofetil le
Completed Study Name: Multicenter Study Evaluating the Performance of the Assay of Anti-hinge Region Antibodies in the Diagnosis of Progressive Forms of IgA Nephropathy
Condition: IgA Nephropathy
Date: 2015-08-17
Interventions: Biological: blood sample dosage of anti-hinge region antibodies
Completed Study Name: The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy
Condition: IgA Nephropathy
Date: 2011-10-07
Interventions: Drug: Prednisone or Prednisolone daily single dose of 1mg/kg (maximum 80mg) or alternate day single dose
Recruiting Study Name: Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy
Condition: Primary IgA Nephropathy
Date: 2016-04-30
Interventions:
  • Drug: Hydroxychloroquine Sulfate

Completed Study Name: Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy
Condition: IgA Nephropathy
Date: 2007-10-25
Interventions: Drug: Omega-3 fatty acid ethylester90 Dosage form :1g soft capsule Dosage : two capsules, twice a day.
Completed Study Name: Probiotics in IgA Nephropathy
Condition: IgA Nephropathy
Date: 2013-01-16
Interventions:
  • Dietary Supplement: ProTectis
  • Dietary Supp
RECRUITING Study Name: Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy
Condition: IgA Nephropathy
Date: 2024-09-16
Interventions: Period A (12 Weeks) - Film-coated tablet, Washout Period: 12 weeks, Period B (24 Weeks) - Placebo
Next >>>